Shanghai - Delayed Quote • CNY
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS)
At close: 3:00 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
41,399,539.59
41,399,539.59
43,951,546.90
39,011,184.28
30,306,981.26
Cost of Revenue
21,595,308.76
21,595,308.76
23,169,690.42
20,229,784.68
13,733,528.78
Gross Profit
19,804,230.83
19,804,230.83
20,781,856.48
18,781,399.60
16,573,452.48
Operating Expense
18,240,906.77
18,240,906.77
17,145,016.83
16,071,626.61
13,743,289.52
Operating Income
1,563,324.06
1,563,324.06
3,636,839.65
2,709,772.99
2,830,162.97
Net Non Operating Interest Income Expense
-997,350.08
-997,350.08
-709,762.38
-618,688.82
-699,483.24
Pretax Income
3,264,567.88
3,264,567.88
4,574,381.58
6,042,670.59
4,677,844.35
Tax Provision
369,504.45
369,504.45
626,917.46
1,066,401.22
737,864.58
Net Income Common Stockholders
2,386,265.81
2,386,265.81
3,730,804.58
4,728,710.53
3,662,812.94
Basic EPS
0.89
0.89
1.43
1.85
1.43
Diluted EPS
0.89
0.89
1.43
1.85
1.43
Basic Average Shares
2,681,197.54
2,681,197.54
2,608,954.25
2,556,059.75
2,561,407.65
Diluted Average Shares
2,681,197.54
2,681,197.54
2,608,954.25
2,556,059.75
2,561,407.65
Total Operating Income as Reported
3,307,507.91
3,307,507.91
4,656,656.38
6,302,568.21
4,721,145.27
Total Expenses
39,836,215.53
39,836,215.53
40,314,707.25
36,301,411.29
27,476,818.30
Net Income from Continuing & Discontinued Operation
2,386,265.81
2,386,265.81
3,730,804.58
4,728,710.53
3,662,812.94
Normalized Income
3,094,377.46
3,094,377.46
6,111,153.40
5,214,094.46
3,383,114.92
Interest Income
363,645.39
363,645.39
282,634.64
233,727.10
199,608.71
Interest Expense
1,324,830.53
1,324,830.53
963,806.92
822,534.03
880,952.45
Net Interest Income
-997,350.08
-997,350.08
-709,762.38
-618,688.82
-699,483.24
EBIT
4,589,398.40
4,589,398.40
5,538,188.50
6,865,204.62
5,558,796.80
EBITDA
7,554,583.03
7,554,583.03
7,874,099.75
8,699,592.89
7,225,018.17
Reconciled Cost of Revenue
21,595,308.76
21,595,308.76
23,169,690.42
20,229,784.68
13,733,528.78
Reconciled Depreciation
2,965,184.63
2,965,184.63
2,335,911.25
1,834,388.27
1,666,221.37
Net Income from Continuing Operation Net Minority Interest
2,386,265.81
2,386,265.81
3,730,804.58
4,728,710.53
3,662,812.94
Total Unusual Items Excluding Goodwill
-798,489.78
-798,489.78
-2,758,384.49
-589,400.41
332,078.81
Total Unusual Items
-798,489.78
-798,489.78
-2,758,384.49
-589,400.41
332,078.81
Normalized EBITDA
8,353,072.81
8,353,072.81
10,632,484.24
9,288,993.30
6,892,939.36
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-90,378.13
-90,378.13
-378,035.67
-104,016.48
52,380.79
12/31/2020 - 8/7/1998
Yahoo Finance Plus Essential access required. Unlock Access